Medihelp to appeal contempt judgment in Elaprase case
Medihelp says it will challenge the judgment while the cost of Elaprase awaits a final decision by the CMS Appeal Board.
#CMSAppealBoard
Services
Investment Rates
Money Market funds
Updated 1 December 2025
Time is running out to influence FSCA’s new Risk Return
Newsletter Subscription
Stay at the top of your game
Subscribe
